Back to Journals » OncoTargets and Therapy » Volume 6

Review

Afatinib: emerging next-generation tyrosine kinase inhibitor for NSCLC

       
Total article views   HTML views PDF downloads Totals
21,920 Dovepress* 13,718+ 3,206 16,924
PubMed Central* 8,202 2,180 10,382
Totals 21,920 5,386 27,306
*Since 5 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar